Clinical trials. A pending subject

被引:2
|
作者
Gil-Extremera, B. [1 ]
Jimenez-Lopez, P. [1 ]
Mediavilla-Garcia, J. D. [1 ]
机构
[1] Univ Granada, Dept Med, Granada, Spain
来源
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 03期
关键词
Clinical trial; Hypertension; Diabetes; Dyslipidaemia; HIGH-RISK PATIENTS; SYSTOLIC HYPERTENSION; EFFICACY; EVENTS; SAFETY; TELMISARTAN; PREVENTION; DEMENTIA; OUTCOMES; OLDER;
D O I
10.1016/j.rce.2017.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials are essential tools for the progress of clinical medicine in its diagnostic and therapeutic aspects. Since the first trial in 1948, which related tobacco use with lung cancer, there have been more than 150,000 clinical trials to date in various areas (paediatrics, cardiology, oncology, endocrinology, etc.). This article highlights the importance for all physicians to participate, over the course of their professional career, in a clinical trial, due to the inherent benefits for patients, the progress of medicine and for curricular prestige. The authors have created a synthesis of their experience with clinical trials on hypertension, diabetes, dyslipidaemia and ischaemic heart disease over the course of almost 3 decades. Furthermore, a brief reference has been made to the characteristics of a phase I unit, as well as to a number of research studies currently underway. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [1] Effects of advertisement methods on success of subject recruitment for clinical research trials.
    Angelini, BL
    Cordoro, KM
    Fireman, P
    Skoner, DP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 24 - 24
  • [2] Ancient clinical trials.
    Lewis, EJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 83 - 84
  • [3] Glycitein for clinical trials.
    Verbruggen, MA
    Olieman, K
    JOURNAL OF NUTRITION, 2002, 132 (03): : 601S - 601S
  • [4] Advancement in KRAS clinical trials.
    Yeung, Wayne
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Use of biomarkers in clinical trials.
    Ransohoff, DF
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2768S - 2768S
  • [6] Ancient clinical trials. Reply
    Lepreau, FJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 84 - 84
  • [7] Planning for oncological clinical trials.
    Odeleye, OE
    Kovacevic, M
    Torchio, CR
    BLOOD, 2000, 96 (11) : 390B - 390B
  • [8] The treatment of fibromyalgia: a review of clinical trials.
    Crofford L.J.
    Appleton B.E.
    Current Rheumatology Reports, 2000, 2 (2) : 101 - 103
  • [9] Blinding for clinical trials.: Does it matter?
    Letelier, LM
    Manríquez, JJ
    Claro, JC
    REVISTA MEDICA DE CHILE, 2004, 132 (09) : 1137 - 1139
  • [10] Consistency as an endpoint in migraine clinical trials.
    Lipton, RB
    CEPHALALGIA, 1999, 19 (04) : 273 - 273